News

June 13, 2019June 13, 2019

Alpha-Blockers May Help Relieve Insomnia, Anxiety in MG Patients, Case Study Suggests

News

People with myasthenia gravis can develop psychiatric symptoms, including depression and insomnia. However, recommendations regarding safe medication are insufficient. In this case study, clinicians suggest that alpha-blockers are a ... Read more

June 11, 2019June 11, 2019

Differences in Gene Activity May Explain Why Some Patients Have Difficult-to-treat Eye Disease, Study Shows

News

Examining differences in the activity of certain genes may help explain why some patients with myasthenia gravis (MG) develop a difficult-to-treat form of the disease in the eyes. Researchers ... Read more

June 6, 2019June 6, 2019

Dropouts in Placebo Groups Due to Adverse Events Are Low in MG Clinical Trials, Study Shows

News

Placebo-treated myasthenia gravis (MG) patients experience as many adverse events as those receiving an active treatment during clinical trials, but this leads to few participant dropouts — and should ... Read more

June 4, 2019June 4, 2019

MG Patients Can Be Considered for Use of Immunotherapies in Cancer Cases, Study Contends

News

The presence of autoimmune diseases, such as myasthenia gravis (MG), should not be seen as a not be seen as a factor against treatment with immune checkpoint inhibitors in ... Read more

May 28, 2019May 28, 2019

Agency Unveils RaDaR to Help Patient Groups Develop Rare Disease Registries

News

RaDaR, the catchy new name for the U.S. government-run Rare Diseases Registry Program, aims to help patient advocacy groups with limited resources build their own disease registries. The site ... Read more

May 28, 2019May 28, 2019

MG Patients with Other Autoimmune Diseases Don’t Have Higher Disease Burden, Study Says

News

Patients with myasthenia gravis (MG) who also have other autoimmune diseases do not have a significantly higher disease burden compared to those with MG alone, a study says. The ... Read more

May 23, 2019May 23, 2019

Rituxan Leads to High Rates of Clinical Remission in MG Patients, Study Reports

News

Treatment with Rituxan (rituximab) led to high rates of clinical remission without posing significant side effects in a group of patients with myasthenia gravis (MG), a study shows. The study, ... Read more

May 21, 2019May 21, 2019

#AANAM — Soliris May Help MG Patients Lower Immunosuppressive Therapy Use, Phase 3 Data Show

News

A significant proportion of patients with generalized myasthenia gravis (MG) treated with Alexion’s Soliris (eculizumab) were able to either stop or reduce their use of immunosuppressive therapy, according to ... Read more

May 16, 2019May 16, 2019

Rare Diseases Constitute a ‘Public Health Issue,’ NCATS Director Warns

News

With 250 rare diseases newly identified every year, scientists can barely keep up — even as the healthcare system fails millions of Americans whose rare diseases have already been ... Read more

May 9, 2019May 9, 2019

#AANAM – Under-the-Skin Immunoglobulin Treatment Maintains Stable Disease Activity, Study Reports

News

Treatment with subcutaneous immunoglobulin (SCIg) — a new formulation given as an under-the-skin injection — enabled people with myasthenia gravis (MG) to maintain stable disease activity while transitioning from ... Read more

Pin It on Pinterest